Sign inGet started

Hefti Franz

Insider CIK 1735529 · PRVL Chief Development Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PRVL Prevail Therapeutics Inc. D To issuer deriv2021-01-222021-01-2662,200— $00SEC↗
PRVL Prevail Therapeutics Inc. D To issuer deriv2021-01-222021-01-2659,844— $00SEC↗
PRVL Prevail Therapeutics Inc. D To issuer deriv2021-01-222021-01-26266,895— $00SEC↗
PRVL Prevail Therapeutics Inc. A Award deriv2020-02-192020-03-1162,200— $062,200SEC↗